2023
DOI: 10.1093/stcltm/szad008
|View full text |Cite
|
Sign up to set email alerts
|

Incorporating Combinatorial Approaches to Encourage Targeted Neural Stem/Progenitor Cell Integration Following Transplantation in Spinal Cord Injury

Abstract: Spinal cord injury (SCI) severely diminishes quality of life and presents patients with a substantial financial burden. The lack of a curative treatment has guided efforts toward identifying potential regenerative treatments. Neural stem/progenitor cell (NSPC) transplantation represents a promising strategy for the regeneration of the injured spinal cord due to the ability of these cells to replace neural cells lost post-injury. However, the transplant-derived oligodendrocytes and neurons need to be able to as… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 74 publications
0
5
0
Order By: Relevance
“…Although these materials have not yet seen widespread use in clinical treatments, numerous pre‐clinical experiments have yielded positive results. [ 302 ] Specifically, we delve into the potential and specific therapeutic enhancements of materials‐assisted strategies at the pre‐clinical stage, focusing on their applications in brain, spinal cord, and peripheral nervous tissues.…”
Section: Pre‐clinical Applications Of Materials‐assisted Emsmentioning
confidence: 99%
“…Although these materials have not yet seen widespread use in clinical treatments, numerous pre‐clinical experiments have yielded positive results. [ 302 ] Specifically, we delve into the potential and specific therapeutic enhancements of materials‐assisted strategies at the pre‐clinical stage, focusing on their applications in brain, spinal cord, and peripheral nervous tissues.…”
Section: Pre‐clinical Applications Of Materials‐assisted Emsmentioning
confidence: 99%
“…Continued studies should focus on extending cell sources, optimizing transplantation strategies and matching pre-clinical animal models with human SCI. In addition to cellular transplantation alone, combinatorial strategies based on NSCs such as co-transplantation therapies, cell delivery methods, enrichment of microenvironment, pharmacotherapeutics, biomaterial scaffolds and neurorehabilitation may have the potential to enhance injury repair following SCI [ 161 163 ]. We are confident that in the near future, NSCs have the potential to make remarkable breakthroughs in both the study of pathological mechanisms and clinical treatments for SCI.…”
Section: Concluding Remarks and Future Perspectivesmentioning
confidence: 99%
“…NSPCs can be derived from various sources, including embryonic and adult neural tissue, as well as iPSCs and ESCs ( Figure 1 ) [ 119 ]. These cells have the inherent ability to generate neural cells, including neurons, astrocytes, and oligodendrocytes [ 120 , 121 ]. NSPC transplantation has shown promise in preclinical studies, promoting functional recovery, reducing lesion size, and enhancing remyelination in animal models of SCI [ 36 ].…”
Section: The Potential Of Different Stem Cell Typesmentioning
confidence: 99%